Nationwide nested case-control data showed current oral hormone therapy increased VTE (HR 1.6), ischemic stroke (HR 1.3), and ...
Despite technology fostering a new generation of health care delivery, experts believe rural health solutions should be ...
Medicaid coverage of obesity-labeled GLP-1 receptor agonists may substitute for, rather than simply add to, diabetes-labeled ...
Clinicians break down HIV PrEP, its near-99% protection, and who’s missing out—women, youth, and Southern communities in PrEP ...
Tozorakimab (MEDI3506) met its primary and key secondary end points in the Phase 3 OBERON ( NCT05166889) and TITANIA ( ...
Lean-mass changes should be interpreted with performance endpoints, including handgrip strength, rather than isolated ...
The FDA approved tavapadon (Juvmo) tablets for the treatment of adults with Parkinson disease (PD). The company described the ...
Documentation limitations were the most frequently identified theme and included the absence of structured menopause-specific ...
Children and adolescents with type 1 diabetes (T1D) who begin continuous glucose monitoring (CGM) within the first month of ...
Menopausal hormone therapy (MHT) initiated during perimenopause or early postmenopause was associated with a 22% reduction in cardiovascular disease (CVD) risk among women with va ...
Pharmacist Eddie Morales is leading the charge to unionize in Connecticut, Rhode Island, and New Jersey. For more information, go to www.cvsworker.com. Contact Eddie at edmrph@hotmail.com for ...
Dorrit Trate, MHA, explored how community pharmacies can improve a multitude of patient experiences through pharma-sponsored support programming. Community pharmacies navigate an increasingly complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results